Robert S. Coffin

7.0k total citations
66 papers, 3.5k citations indexed

About

Robert S. Coffin is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Robert S. Coffin has authored 66 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Genetics, 25 papers in Epidemiology and 22 papers in Molecular Biology. Recurrent topics in Robert S. Coffin's work include Virus-based gene therapy research (44 papers), Herpesvirus Infections and Treatments (25 papers) and CAR-T cell therapy research (18 papers). Robert S. Coffin is often cited by papers focused on Virus-based gene therapy research (44 papers), Herpesvirus Infections and Treatments (25 papers) and CAR-T cell therapy research (18 papers). Robert S. Coffin collaborates with scholars based in United Kingdom, United States and India. Robert S. Coffin's co-authors include David S. Latchman, Kevin J. Harrington, Howard L. Kaufman, Colin Love, Howard Goldsweig, Neil Senzer, Thomas Amatruda, Marcus Wagstaff, Iain A. McNeish and Christopher M. Nutting and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Robert S. Coffin

65 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert S. Coffin United Kingdom	30	1.5k	1.5k	1.3k	875	718	66	3.5k
Yumi Kanegae Japan	36	1.9k 1.2×	3.6k 2.4×	1.2k 0.9×	768 0.9×	1.0k 1.4×	94	5.9k
Ya‐Wen Chiang United States	26	2.6k 1.7×	2.6k 1.7×	1.3k 1.0×	544 0.6×	502 0.7×	42	4.5k
Udo Baron Germany	27	1.5k 1.0×	2.7k 1.8×	931 0.7×	3.4k 3.8×	473 0.7×	44	6.8k
Patrick Salmon Switzerland	32	1.0k 0.7×	2.2k 1.5×	584 0.4×	853 1.0×	308 0.4×	60	3.9k
Jane Lebkowski United States	44	1.1k 0.7×	4.3k 2.9×	766 0.6×	783 0.9×	174 0.2×	92	5.8k
Leslie D. Stratford-Perricaudet France	15	3.2k 2.1×	3.1k 2.1×	596 0.4×	307 0.4×	504 0.7×	18	4.8k
Xiao Xiao United States	29	3.4k 2.2×	4.0k 2.7×	761 0.6×	289 0.3×	421 0.6×	69	5.3k
Masashi Urabe Japan	29	1.7k 1.1×	2.2k 1.4×	547 0.4×	267 0.3×	308 0.4×	98	3.3k
Derek A. Persons United States	37	1.8k 1.2×	2.9k 1.9×	754 0.6×	668 0.8×	280 0.4×	74	4.7k
Romain Zufferey Switzerland	22	4.4k 2.8×	5.7k 3.8×	1.2k 0.9×	1.0k 1.2×	744 1.0×	30	8.2k

Countries citing papers authored by Robert S. Coffin

Since Specialization

Citations

This map shows the geographic impact of Robert S. Coffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Coffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Coffin more than expected).

Fields of papers citing papers by Robert S. Coffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Coffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Coffin. The network helps show where Robert S. Coffin may publish in the future.

Co-authorship network of co-authors of Robert S. Coffin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Coffin. A scholar is included among the top collaborators of Robert S. Coffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Coffin. Robert S. Coffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergerhoff, Katharina, Shane Foo, Emmanuel C. Patin, et al.. (2020). Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer. Journal for ImmunoTherapy of Cancer. 8(2). e000698–e000698. 24 indexed citations

Middleton, Mark R., Francesca Aroldi, Joseph J. Sacco, et al.. (2020). An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts.. Journal of Clinical Oncology. 38(15_suppl). e22050–e22050. 16 indexed citations

Kaufman, Howard L., Caroline E. Lilley, Rafael Ponce, Tasha M. Hughes, & Robert S. Coffin. (2014). Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma. PubMed. 3. 11–11. 18 indexed citations

Kaufman, Howard L., Robert Hans Ingemar Andtbacka, Frances A. Collichio, et al.. (2014). Primary overall survival (OS) from OPTiM, a randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.. Journal of Clinical Oncology. 32(15_suppl). 9008a–9008a. 36 indexed citations

Harrington, Kevin J., Mohan Hingorani, Mary Anne Tanay, et al.. (2010). Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck. Clinical Cancer Research. 16(15). 4005–4015. 216 indexed citations

Wong, Joyce, Kaitlyn J. Kelly, Arjun Mittra, et al.. (2010). A Third-Generation Herpesvirus Is Effective Against Gastroesophageal Cancer. Journal of Surgical Research. 163(2). 214–220. 9 indexed citations

Price, Daniel L., Shu‐Fu Lin, Guy R. Simpson, et al.. (2010). Oncolysis Using Herpes Simplex Virus Type 1 Engineered to Express Cytosine Deaminase and a Fusogenic Glycoprotein for Head and Neck Squamous Cell Carcinoma. Archives of Otolaryngology - Head and Neck Surgery. 136(2). 151–151. 10 indexed citations

Coffin, Robert S., et al.. (2009). Delivery of RNA interference triggers to sensory neuronsin vivousing herpes simplex virus. Expert Opinion on Biological Therapy. 10(1). 89–103. 6 indexed citations

Thornton, Mark, Philip A. Reay, R. Jennings, et al.. (2008). Delivery of HPV Antigens Using a Modified HSV-2 Vector: Development of a Combined Vaccine for HPV and HSV-2. Central European Journal of Public Health. 16. 1 indexed citations

10.

Leclere, Pascal G, et al.. (2007). Impaired Axonal Regeneration by Isolectin B4-Binding Dorsal Root Ganglion NeuronsIn Vitro. Journal of Neuroscience. 27(5). 1190–1199. 63 indexed citations

11.

Nonoguchi, Naosuke, et al.. (2007). VASCULAR ENDOTHELIAL GROWTH FACTOR GENE-TRANSFERRED BONE MARROW STROMAL CELLS ENGINEERED WITH A HERPES SIMPLEX VIRUS TYPE 1 VECTOR CAN IMPROVE NEUROLOGICAL DEFICITS AND REDUCE INFARCTION VOLUME IN RAT BRAIN ISCHEMIA. Neurosurgery. 61(3). 586–595. 47 indexed citations

12.

Kitamura, Kazuya, Akio Iwanami, Masaya Nakamura, et al.. (2007). Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. Journal of Neuroscience Research. 85(11). 2332–2342. 133 indexed citations

13.

Pollara, Gabriele, Laila Samady, Yvonne McGrath, et al.. (2003). Herpes Simplex Virus Infection of Dendritic Cells: Balance among Activation, Inhibition, and Immunity. The Journal of Infectious Diseases. 187(2). 165–178. 102 indexed citations

14.

Akbar, Mohammed T., et al.. (2003). Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss. Molecular Brain Research. 111(1-2). 91–103. 50 indexed citations

15.

Levy, M. Susana, et al.. (2003). Impact of Process Conditions on the Centrifugal Recovery of a Disabled Herpes Simplex Virus. Biotechnology Progress. 19(1). 209–215. 8 indexed citations

16.

Wright, Matthew, Lionel Wightman, Caroline E. Lilley, et al.. (2001). In vivo myocardial gene transfer: Optimization, evaluation and direct comparison of gene transfer vectors. Basic Research in Cardiology. 96(3). 227–236. 74 indexed citations

17.

Hudde, Tobias, Sandra Rayner, Mahesh de Alwis, et al.. (2000). Adeno-associated and Herpes Simplex Viruses as Vectors for Gene Transfer to the Corneal Endothelium. Cornea. 19(3). 369–373. 42 indexed citations

18.

Latchman, David S. & Robert S. Coffin. (2000). Viral vectors in the treatment of Parkinson's disease. Movement Disorders. 15(1). 9–17. 19 indexed citations

19.

Gough, Gerald, et al.. (1998). Cell type specific repression of the varicella zoster virus immediate early gene 62 promoter by the cellular Oct-2 transcription factor. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1397(3). 268–274. 9 indexed citations

20.

Wagstaff, Marcus, Yolanda Collaço‐Moraes, B S Aspey, et al.. (1996). Focal cerebral ischaemia increases the levels of several classes of heat shock proteins and their corresponding mRNAs. Molecular Brain Research. 42(2). 236–244. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact